An Inulin-Type Fructan CP-A from Codonopsis pilosula Alleviated 5-Fluorouracil-Induced Intestinal Mucositis via the ERK/MLCK/MLC2 Pathway and Regulation of Gut Microbiota

Jiangtao Zhou,Deyun Li,Jiajing Wang,Zhuoyang Cheng,Changjian Wang,Xuepeng Zhang,Xiexin Xu,Jianping Gao

DOI: https://doi.org/10.3390/ph17030297

IF: 4.6

2024-02-27

Pharmaceuticals

Abstract:Intestinal mucositis (IM) is a common adverse effect of chemotherapy, limiting its clinical application. Codonopsis pilosula-derived CP-A (an inulin-type fructan) is an edible Chinese medicine with anti-inflammatory and gastrointestinal protective effects, which may be useful for treating IM. Here, we explored CP-A's role in ameliorating IM induced by 5-fluorouracil (5-FU) and investigated the underlying mechanism using in vitro experiments and rat models. Western blotting, immunohistochemistry (IHC), and real-time PCR (RT-PCR) analyses were used to assess protein expression related to the extracellular-regulated protein kinases (ERK)/myosin light chain kinase (MLCK)/myosin light chain 2 (MLC2) signaling pathway and tight junction proteins. Inflammatory factors were quantified using enzyme-linked immunosorbent assays (ELISAs), and 16S rRNA amplicon sequencing was employed for cecum content analysis. The results indicated that CP-A restored body weight and food intake and reversed histopathological changes in IM rats. Further, abnormal MLCK activation induced by 5-FU was attenuated by CP-A via the ERK/MLCK/MLC2 pathway. CP-A treatment improved tight junction protein levels and reduced inflammatory factor expression. Moreover, CP-A intervention regulated the intestinal microbiota community structure, increasing the abundance of Lactobacillus and decreasing the abundance of Shigella. In conclusion, CP-A mitigates 5-FU-induced IM by inhibiting the ERK/MLCK/MLC2 pathway, reducing the expression of inflammatory factors, improving the intestinal mucosal barrier, and regulating the intestinal microbial community. This study highlights CP-A's therapeutic potential in IM treatment and provides insights for future research.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

### What problem does this paper aim to solve?

This paper primarily explores the therapeutic effects and potential mechanisms of an inulin-type fructan CP-A derived from *Codonopsis pilosula* on 5-fluorouracil (5-FU)-induced intestinal mucositis. Specifically, the study investigates whether CP-A can alleviate 5-FU-induced intestinal mucositis through in vitro experiments and rat models, and delves into its mechanisms of action. The research found that CP-A can effectively reduce the symptoms of 5-FU-induced intestinal mucositis by inhibiting the ERK/MLCK/MLC2 signaling pathway, reducing the expression of inflammatory factors, improving intestinal mucosal barrier function, and regulating the structure of the gut microbiota. This study provides valuable insights for the development of new treatments for intestinal mucositis.